G
Ganga Pharmaceuticals
GANGAPHARM Share Price
Healthcare12.00
as on 13 Mar 2026 at 00:00
BSE
Market Cap
₹7 Cr
PE Ratio
92.30
ROCE
3.71%
GANGAPHARM Fundamentals
Company Valuation
Market Cap (₹ Cr.)
7
PE Ratio
92.30
PB Ratio
0.89
Dividend Yield
-
ROE
1.11%
ROCE
3.71%
Book Value (₹)
13.56
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Sep 2024 | Mar 2025 | Jun 2025 | Jul 2025 | Sep 2025 |
|---|---|---|---|---|---|
| Promoters | 56.02% | 56.02% | 50.91% | 50.91% | 50.91% |
| Domestic Institutional Investors (DII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 35.23% | 35.07% | 35.46% | 35.46% | 35.32% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GANGAPHARM Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
SME
BSE Scrip Code
539680
NSE Scrip Name
GANGAPHARM
ISIN
INE615T01017



